Immune Reprogramming via PD-1 Inhibition Enhances Early-Stage Lung Cancer Survival
JCI insight - United States
doi 10.1172/jci.insight.96836
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 12, 2018
Authors
Publisher
American Society for Clinical Investigation